SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-13-046836
Filing Date
2013-12-18
Accepted
2013-12-18 19:04:59
Documents
1
Period of Report
2013-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 11108
  Complete submission text file 0001140361-13-046836.txt   12793
Mailing Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390
Raptor Pharmaceutical Corp (Issuer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RAPTOR PHARMACEUTICAL INC. 9 COMMERCIAL BLVD., SUITE 200 NOVATO CA 94949
Business Address
STARR CHRISTOPHER M (Reporting) CIK: 0001235470 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25571 | Film No.: 131286496